Effect of Statins on the Risk of Different Stages of Prostate Cancer: A Meta-Analysis.

Li, Yun; Cheng, Xuan; Zhu, Jia-Lian; Luo, Wen-Wen; Xiang, Huai-Rong; Zhang, Qi-Zhi; Peng, Wen-Xing

Li, Yun; Cheng, Xuan; Zhu, Jia-Lian; Luo, Wen-Wen; Xiang, Huai-Rong; Zhang, Qi-Zhi; Peng, Wen-Xing.

Afiliação

Li Y; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, China.
Cheng X; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, China.
Zhu JL; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, China.
Luo WW; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, China.
Xiang HR; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, China.
Zhang QZ; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, China.
Peng WX; Department of Pharmacy, the Second Xiangya Hospital, Central South University, Changsha, China.

Urol Int ; 106(9): 869-877, 2022.

Article em En | MEDLINE | ID: mdl-34518476

Assuntos

Inibidores de Hidroximetilglutaril-CoA Redutases; Neoplasias da Próstata; Humanos; Inibidores de Hidroximetilglutaril-CoA Redutases/efeitos adversos; Incidência; Masculino; Próstata; Neoplasias da Próstata/epidemiologia; Neoplasias da Próstata/prevenção & controle; Risco

Palavras-chave

Advanced prostate cancer; High-grade prostate cancer; Meta-analysis; Statins

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Inibidores de Hidroximetilglutaril-CoA Redutases Tipo de estudo: Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans / Male Idioma: En Revista: Urol Int Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google